Kenvue, which was spun off from Johnson & Johnson in 2023, has been working to shore up profitability, especially in its struggling skin health and beauty unit which includes brands like Neutrogena and Aveeno. Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday (Jul 14), laying what some investors expect will be the groundwork for an eventual sale of the entire company or pieces of it. Kenvue also said that an ongoing review of